We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Roche Sells Drugs of Abuse Testing Business to Varian

In a move to divest a business whose market is not important to the company's current strategy, Roche Diagnostics has sold its worldwide nonclinical drugs of abuse testing (DAT) business to Varian, Inc. for an undisclosed amount. More...
30 Nov -0001

Companies Restructure Agreement on Oxygen Carrier

A new agreement has been announced whereby Alliance Pharmaceutical Corp. will acquire an option to purchase the ownership interest of Baxter Healthcare Corp. More...
30 Nov -0001

DPC Granted License to Develop Cancer Diagnostics

A license to develop and commercialize diagnostic assays based on two novel prostate-specific proteins for detecting and monitoring prostate cancer and perhaps other cancers has been granted to Diagnostic Products Corp. by Compugen, Ltd. More...
30 Nov -0001

SpectRx Regains Rights to Glucose Monitoring Technology

A research, development, and license agreement on continuous glucose monitoring technology with Abbott Laboratories has been terminated, according to an announcement by SpectRx, Inc., which has regained rights to the technology.
More...
30 Nov -0001

Savyon Diagnostics to Spin Off Nongenetic Lab Business

An agreement to organize a new Israeli company to acquire the clinical laboratory diagnostics business of Savyon Diagnostics, Ltd., a subsidiary of Healthcare Technologies, for around US$1.9 million has been announced More...
30 Nov -0001

TriPath and AmeriPath to Develop Melanoma Assay

An agreement to commercialize a novel gene expression assay for malignant melanoma has been announced by TriPath Oncology,Inc. and AmeriPath, Inc. More...
30 Nov -0001

Alliance for Molecular Bladder Cancer Detection

An agreement to sublicense exclusive worldwide diagnostic rights to develop and commercialize an immunohistochemistry test to detect the presence of the CD52 antigen in lymph nodes has been announced by Ilex Oncology, Inc. More...
30 Nov -0001
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
PURITAN MEDICAL